On the contrary, the antagonistic monoclonal antibody against ICOS can not only inhibit the lymphoid tumor cells expressing ICOS, but also inhibit the immunosuppressive Treg (Amatore et al., 2018). This evidence concerns the gene ICOS and lymphoid neoplasm.